We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+35.87%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$211M
AUM Growth
-$31.9M
Cap. Flow
-$83.2M
Cap. Flow %
-39.42%
Top 10 Hldgs %
8.5%
Holding
499
New
89
Increased
112
Reduced
218
Closed
57

Sector Composition

Rank Sector Weight
1 Healthcare 33.94%
2 Real Estate 15.9%
3 Energy 15.5%
4 Materials 8.79%
5 Financials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
201
DELISTED
Athenex, Inc. Common Stock
ATNX
$393K 0.19%
1,427
+192
+16% +$40.6K
KDMN
202
DELISTED
Kadmon Holdings, Inc.
KDMN
$392K 0.19%
76,646
+638
+0.8% +$2.86K
ASMB icon
203
Assembly Biosciences
ASMB
$515M
$391K 0.19%
1,398
+2
+0.1% +$467
BTAI icon
204
BioXcel Therapeutics
BTAI
$26.9M
$391K 0.19%
+461
New +$301K
FATE icon
205
Fate Therapeutics
FATE
$280M
$391K 0.19%
11,389
-7,746
-40% -$231K
MRTX
206
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$391K 0.19%
3,424
+213
+7% +$20.7K
ODT
207
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$391K 0.19%
9,244
-3,166
-26% -$102K
DTIL icon
208
Precision BioSciences
DTIL
$194M
$390K 0.18%
1,561
+396
+34% +$86.7K
RYTM icon
209
Rhythm Pharmaceuticals
RYTM
$7.41B
$390K 0.18%
17,484
+2,260
+15% +$44K
BCRX icon
210
BioCryst Pharmaceuticals
BCRX
$2.47B
$389K 0.18%
81,644
-39,414
-33% -$157K
BHVN
211
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$389K 0.18%
5,318
-1,539
-22% -$81.9K
CRNX icon
212
Crinetics Pharmaceuticals
CRNX
$8.88B
$386K 0.18%
+22,026
New +$375K
CYTK icon
213
Cytokinetics
CYTK
$11B
$386K 0.18%
16,388
-17,366
-51% -$326K
MIRM icon
214
Mirum Pharmaceuticals
MIRM
$6.96B
$386K 0.18%
+19,835
New +$331K
DCPH
215
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$386K 0.18%
6,459
+887
+16% +$47.4K
EDIT icon
216
Editas Medicine
EDIT
$407M
$384K 0.18%
+12,987
New +$339K
AMRS
217
DELISTED
Amyris Inc.
AMRS
$384K 0.18%
90,045
-20,247
-18% -$67.3K
PTGX icon
218
Protagonist Therapeutics
PTGX
$8.85B
$382K 0.18%
+21,639
New +$271K
NTLA icon
219
Intellia Therapeutics
NTLA
$1.5B
$380K 0.18%
+18,100
New +$307K
PRTA icon
220
Prothena Corp
PRTA
$455M
$379K 0.18%
+36,223
New +$402K
WVE icon
221
Wave Life Sciences
WVE
$1.14B
$379K 0.18%
36,361
+26,803
+280% +$252K
CGEN icon
222
Compugen
CGEN
$224M
$378K 0.18%
+25,176
New +$340K
TCDA
223
DELISTED
Tricida, Inc. Common Stock
TCDA
$377K 0.18%
13,718
+4,614
+51% +$126K
DSU icon
224
BlackRock Debt Strategies Fund
DSU
$589M
$376K 0.18%
40,258
-185,009
-82% -$1.72M
KZR
225
DELISTED
Kezar Life Sciences
KZR
$375K 0.18%
+7,238
New +$365K

Similar funds

Virtus ETF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Virtus ETF Advisers held 499 positions worth $211M, down 13% from $243M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Virtus ETF Advisers withdrew a net $83.2M in Q2 2020, closing 57 positions and reducing 218 holdings. Its most notable exit was Tallgrass Energy, LP Class A Shares, an estimated $1.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 20% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Verastem worth $342K.

  • Virtus ETF Advisers's largest Q2 2020 buy was Verastem: 16,584 shares worth $342K.
  • Virtus ETF Advisers added most to Delek Logistics in Q2 2020, an estimated $1.29M increase.
  • Virtus ETF Advisers's biggest Q2 2020 reduction was Barings BDC, cutting an estimated $2.49M.
  • Virtus ETF Advisers fully exited Tallgrass Energy, LP Class A Shares in Q2 2020, selling an estimated $1.22M.
  • Virtus ETF Advisers's ten largest holdings make up 8.5% of its $211M portfolio in Q2 2020.
  • Virtus ETF Advisers opened 89 new positions and closed 57 in Q2 2020.
  • Virtus ETF Advisers's portfolio value fell 13% quarter-over-quarter to $211M.

Based on Virtus ETF Advisers's 13F filing for Q2 2020, filed 5 Aug 2020.